Amber Tong – Page 71 – Endpoints News

about the author

Amber Tong

amber@endpointsnews.com @AmberTongPW

Amber Tong on LinkedIn

author articles

Tricida 'foreshadowed' its CRL — but shares still fall with fear of years-long delay

5 years ago

Odonate announces 'positive' results but faces investor backlash; Aslan is once again recruiting clinical trial ...

5 years ago

Vir enlists Covid-19 antibody rival for cancer, infectious disease discovery work

5 years ago

Covid-19 roundup: Novavax begins PhII trial in US and Australia; AstraZeneca signs US manufacturing deal with ...

5 years ago

Lilly Asia Ventures leads AstraZeneca spinout's $100M push into China's growing R&D hub in Wuxi

5 years ago

BioMarin submits NDA for controversial achondroplasia drug; Cell and gene therapy boom sparks €49M buyout

5 years ago

Covid-19 roundup: J&J plans 60,000-person PhIII for September; Peter Marks draws a red line

5 years ago

Seven PD-(L)1 players could be vying for a place on China's drug reimbursement list. How far will they go?

5 years ago

Covid-19 roundup: Pfizer/BioNTech spell out PhIII priority; Legal experts urge FDA to refrain from vaccine EUAs

5 years ago

Turning Point touts positive pivotal NSCLC data, hints at even faster OK — but can it beat Pfizer and Roche?

5 years ago

Covid-19 roundup: Fauci, Collins intervene to stop FDA plasma authorization, citing weak data; Roche, Regeneron try ...

5 years ago

Covid-19 roundup: Inside CTAP: 270 trials underway, 570+ in the FDA line; WHO chief calls out 'vaccine nationalism'

5 years ago

KKR healthcare vet Jim Momtazee jump starts a new investment firm; Bayer signs up a top China biotech player to $645M ...

5 years ago

Taysha buys clinic-ready gene therapy from Abeona, bringing Steven Gray's portfolio back in one place

5 years ago

Teamed up with Lyell, Juno/WuXi joint venture files IPO betting on China's CAR-T future

5 years ago

Martin Shkreli continued to orchestrate anti-competitive schemes for Daraprim behind bars — FTC

5 years ago

Covid-19 roundup: AstraZeneca signs 400M vaccine supply deal with EU; Sinopharm reports positive Phase I/II data for ...

5 years ago

TG Therapeutics scores priority review for PI3Kδ inhibitor; Galapagos searches for IBD targets in new pact

5 years ago

CanSino reaps $748M windfall from Shanghai IPO — as it warns Covid-19 vaccine won't be a huge money maker

5 years ago

Novartis’ CAR-T partner in China wraps $383M take-private deal engineered by CEO

5 years ago

Novo backs 'breakthrough' antifungal player's $60M round — with a focus on rare mold infections

5 years ago

Moderna offers steep discount in US supply deal — but still takes the crown with close to $2.5B in vaccine ...

5 years ago

Perceptive births its first in-house startup — and it's a China play

5 years ago

Hunting a blockbuster, Bayer forges an $875M-plus M&A deal to acquire women’s health biotech

5 years ago

First page Previous page 68 69 707172 73 74 Next page Last page